Improving Survival Rates: Biotech Innovations in Pancreatic Cancer Treatment
Provided By PR Newswire
Last update: Nov 29, 2023
FN Media Group Presents USA News Group News Commentary
VANCOUVER, BC, Nov. 29, 2023 /PRNewswire/ -- USA News Group - According to the European Cancer Information System (ECIS), new cancer cases and deaths are on the rise in the EU. Sadly, this is a trend that's happening in North America too, especially among young people. Perhaps the most concerning are the incidences of pancreatic cancer, which while only being the 4th most common cause of death, remains one of the lowest survival rates among all cancers. Despite the dire odds, several biotech developers are working diligently to find treatments to enhance the chances of those who've been unlucky enough to contract pancreatic cancer. Among the top developers putting out promising results with new treatments are Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC), Exelixis, Inc. (NASDAQ:EXEL), Mirati Therapeutics, Inc. (NASDAQ:MRTX), Eli Lilly and Company (NYSE:LLY), and POINT Biopharma Global Inc. (NASDAQ:PNT).
Read more at prnewswire.comNYSE:LLY (5/13/2025, 3:27:07 PM)
749.805
-5.77 (-0.76%)
NASDAQ:EXEL (5/13/2025, 3:27:07 PM)
37.03
+0.05 (+0.14%)
NASDAQ:ONCY (5/13/2025, 3:24:47 PM)
0.52
-0.02 (-3.7%)
Find more stocks in the Stock Screener
LLY Latest News and Analysis
14 hours ago - ChartmillMarket Monitor News May 12 ( NRG Energy, Amazon, Meta Platforms UP - CVS Health DOWN)Wall Street Surges on Temporary Trade Truce Between US and China
a day ago - ChartmillLet's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
a day ago - ChartmillTop S&P500 movers in Monday's pre-market sessionGet insights into the top gainers and losers in the S&P500 index of Monday's pre-market session.
5 days ago - ChartmillMarket Monitor May 9 (Boeing, MicroStrategy UP - Match Group DOWN)U.S. Markets Rise on Trade Deal Hopes and Boeing Boost
5 days ago - ChartmillDiscover which S&P500 stocks are making waves on Thursday.Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session.
5 days ago - ChartmillThursday's session: gap up and gap down stock in the S&P500 indexWondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.
6 days ago - ChartmillTop gainers and losers in the S&P500 index during Wednesday's after-hours session.Discover the top S&P500 movers in Wednesday's after-hours session and stay informed about the post-market dynamics.
7 days ago - ChartmillWhat's going on in today's session: S&P500 moversUncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.
7 days ago - ChartmillUncover the latest developments among S&P500 stocks in today's session.Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
11 days ago - ChartmillWhich S&P500 stocks are moving before the opening bell on Friday?Before the opening bell on Friday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.
12 days ago - ChartmillMarket Monitor May 2 ( Microsoft, Meta UP - Eli Lilly DOWN)Wall Street Rebounds as Microsoft and Meta Impress, Eyes Turn to Jobs Report and Tariff Tensions
12 days ago - ChartmillExplore the top gainers and losers within the S&P500 index in today's session.Stay informed about the performance of the S&P500 index one hour before the close of the markets on Thursday. Uncover the top gainers and losers in today's session for valuable insights.
